Skip to main content
SAGE Open Medicine logoLink to SAGE Open Medicine
. 2022 Mar 18;10:20503121221085109. doi: 10.1177/20503121221085109

Musculoskeletal disorders among the population in Northwest Ethiopia

Yoseph Merkeb Alamneh 1,, Bickes Wube Sume 1, Abtie Abebaw Shiferaw 2
PMCID: PMC8935578  PMID: 35321461

Abstract

Objective:

This study aimed to assess the magnitude and patterns of chronic musculoskeletal disorders among the population in East Gojjam zone, Northwest Ethiopia.

Methods:

A community-based cross-sectional study with 846 recruited study participants was done using a multistage sampling technique in conjunction with a simple and systematic random sampling technique. Face-to-face interviews, physical examinations, a semi-structured questionnaire adapted from the Community Oriented Program for Control of Rheumatic Diseases, and other literature were used to collect data. EpiData 3.1 was used to enter the data, which were then exported to STATA 14.0 for analysis.

Result:

The study had a response rate of 98.8%, with about 836 people out of a total of 846 expected to take part. The magnitude of musculoskeletal disorders was found to be 40.1%. Back pain was the most common musculoskeletal condition (16%) of the population, followed by osteoarthritis (10%) and other forms of arthritis (rheumatoid arthritis (8%), gout arthritis (6%)). The most common comorbidity (multimorbidity) patterns were hypertension (9.8%), diabetes (5.6%), obesity (3.9%), and others (2.2%).

Conclusion:

Almost one in four participants have at least one musculoskeletal disorder in Northwest Ethiopia. Rheumatoid arthritis, osteoarthritis, low back pain, and gout arthritis were the most common musculoskeletal disorders. The most common comorbidity patterns were hypertension, diabetes, obesity, and others. An in-depth investigation of the musculoskeletal burden at the national level will be critical for implementing evidence-based strategies, as well as early detection and screening, linking to health institutions, and direct interventions.

Keywords: Musculoskeletal disorders, patterns of comorbidities, Northwest Ethiopia

Introduction

The increasing prevalence of chronic non-communicable diseases (NCDs) is a serious concern throughout the world, as they are the leading cause of disease, disability, and mortality and have a significant influence on the healthcare system. Approximately 1.71 billion people suffer from musculoskeletal (MSK) conditions worldwide. 1

Musculoskeletal disorders (MSDs), which encompass more than 150 conditions affecting the bones, muscles, ligaments, and other connective tissues, are one of the world’s leading causes of chronic morbidity and disability, and a major contributor, accounting for 1.7%−3.4% of the global disease burden. 2 MSDs are the leading cause of activity limitation, loss of function, and long-term disability, as they cause fatigue, leading to early retirement from work, pain, and deformity of a joint. Back and neck pain, osteoarthritis (OA), rheumatoid arthritis (RA), and fractures are among the most disabling MSDs, posing considerable difficulties to healthy aging by reducing physical, mental, and functional capacities. 3

Globally, the burden of disease is changing away from communicable diseases to long-term NCDs, which typically include MSDs. 4 In the 2017 Global Burden of Disease (GBD) study, lower back pain remained the leading cause of disability, with MSDs accounting for three of the top 10 conditions in terms of disability and NCD burden, accounting for 16% of all years lived with disability (YLDs). 5 MSDs account for a higher proportion of overall YLDs in developed countries, and the growth was more gradual, rising from 27.3% in 1990 to 28.1% in 2010. 6 In the developed and developing countries, MSDs and disease burden account for only 3.4% and 1.7%, respectively. 7

MSDs are the most prevalent chronic disorders in the developing world, ranked second in the East Mediterranean and third in Africa, and they are on the rise among the general and working populations. 8 MSDs are the second most common cause of years lost to disability, according to GBD 2017, yet years of life lost in sub-Saharan Africa are decreasing, while the burden of MSDs will only increase as the sub-Saharan population ages. 9 Due to an emphasis on more serious and life-threatening health problems such as infectious illnesses, MSDs are less emphasized and empirically unrepresented in low- and middle-income countries (LMICs), particularly in Ethiopia. 10

MSDs are common occupational health issues that are characterized by a variety of symptoms such as pain, stiffness, and discomfort in various body locations that are either caused or exacerbated by poor fitness and poor health habits, but a large proportion of MSDs are caused by physical work exposures.11,12 According to studies, the prevalence of work-related MSDs in Ethiopia’s adult population ranges from 35% to 74.5%. 13

According to the World Health Organization (WHO) report, the increased prevalence of MSDs has been associated with both work-related and nonwork-related exposures. 14 The WHO and the International League of Associations for Rheumatology (ILAR) developed the Community Oriented Program for Control of Rheumatic Diseases (COPCORD) to collect information on MSK diseases as a major public health problem due to secondary disability and increased use of health resources. 15 Although the WHO-ILAR COPCORD recommends population-based epidemiological studies to assess the burden of MSDs in developing countries, previous studies in Ethiopia revealed that MSDs are focused on work-related (office workers) conditions, excluding large segments of the population such as farmers, unemployed, non-office workers, housewives, and others.1619 As a result, despite extensive study on MSDs in the developed world, there is a paucity of information in Ethiopia that comprehensively analyzes the magnitude and patterns (pain locations, frequency, and distribution over the body) of chronic MSDs. Therefore, the reasons mentioned above triggered us to conduct this research to assess the magnitude and patterns of comorbidities of chronic MSDs among the population in Northwest Ethiopia. Furthermore, the finding of this research is essential for collecting population data, educating the community, identifying risk factors, early detection and screening, and linkage to health institutions. The study’s findings will also be used to develop evidence-based policies and guidelines for hospital administrators, health professionals, regional and national policymakers, and program managers in developing nations, including Ethiopia. In addition, the results of this study will be used as baseline data for future scholars.

Materials and methods

Study design, period, and area

A community-based cross-sectional study design was conducted in East Gojjam zone, from January 2018 to October 2018. East Gojjam zone districts include: Aneded, Awabel, Baso Liben, Bibugn, Debay Telatgen, Debre Elias, Debre Markos Town, Dejen, Enarj Enawga, Enbise Sar Midir, Enemay, Goncha, Goncha Siso Enese, Gozamin, Hulet Ej Enese, Machakel, Shebel Berenta, and Sinan. Debre Markos town, the capital city of East Gojjam zone, is located 300 km northwest from Addis Ababa, the capital city of Ethiopia. According to the 2007 Population and Housing Census of Ethiopia, the projected total population of the zone was 2,451,959 (1,199,952 males and 1,252,006 females). 20

Population

The source populations were all adults who are residing in East Gojjam zone for at least 6 months. The study population was all adults from randomly selected kebeles living in the East Gojjam zone for at least 6 months.

Eligibility criteria

All adult (18+ years old) participants who had lived in the study area for at least 6 months before the study were included, and participants who were critically ill during the study period and those with MSD congenital disorders were excluded from the study. In addition, participants who reported any history of fractures or soft tissue injuries in any location of the body in the previous 6 months were excluded to minimize overestimation.

Sample size determination and sampling procedures

The sample size (846 participants) is determined using single population proportion formula by assuming 95% confidence level, 5% margin of error, 50% proportion of musculoskeletal disorders (MDs), design effect of 2, and 10% non-response rate. Due to the use of multistage sampling technique, the design effect was taken into account to reduce sampling error and ensure representativeness

n=(zα/2)2×p(1p)d2=(1.96)2×0.5(10.5)(0.05)2=384+39=423×2=846_

Regarding sampling procedures, the multistage sampling method was used to select the study participants. First, six districts (30% of districts) such as Debre Markos town, Machakel, Bibugn, Dejen, Enbise Sar Midir, and Hulet Ej Enese were selected randomly using a lottery method from a total of 17 districts of the East Gojjam zone. Second, the district was classified into kebeles and some of the kebeles were selected using a simple random sampling technique (lottery method). Finally, households from each of the kebeles were selected using a systematic sampling technique. The numbers of households sampled from the selected kebeles were determined using proportionate-to-population size (the number of populations in each selected kebele divided by total population from all selected kebeles and multiplied by total sample size). The sampling interval (K) value was calculated for each selected kebele by dividing the total households in each selected kebele by the corresponding proportional sample size (total number of basic sampling units in the population divided by the number of sampling units needed for the sample). The first household was selected using the lottery method; if there are two or more study units within the household, the lottery method was used to select the participants. Then the next household was selected at every Kth interval. If there was no eligible candidate in a selected household or the selected household is closed even after revisit, the sampling process was continued to the next household until getting an eligible participant.

Study variables

The magnitude and pattern of chronic MSD comorbidity were dependent variables, while demographic factors like age, sex, educational background, occupation, and ethnicity; chronic diseases such as diabetes mellitus, hypertension, obesity, and others; behavioral and occupational characteristics like alcohol consumption, smoking, working posture, duration of working hours, and physical activity were independent variables.

Data collection tools and procedure

The data were obtained through a face-to-face interview at the respondents’ homes, using a pre-tested (5% of the study population) and standardized questionnaire. The questionnaire covered MSK problems, sociodemographic factors, behavioral and occupational characteristics, and chronic diseases. The questionnaire was initially written in English and translated into Amharic with cultural adaptations (local and national language), and then translated back to English with cultural adaptations to ensure consistency. The main questionnaire used in this survey to identify MSDs was the COPCORD Core Questionnaire, 21 and it was developed by reviewing the relevant literature. The questionnaire included socioeconomic status, demographics, work-related MSDs, medical and surgical conditions, pain intensity, physical limitation, and help-seeking behavior. Data on the population were collected in three stages: first, to find cases, a local health worker conducted a house-to-house survey; second, the community nurse used interview-based questionnaires to record pain and disability; and finally, all patients who reported pain, swelling, or stiffness in the last 7 days or at any point in their lives were considered positive for clinical assessment by trained health professionals, and a standard medical evaluation was performed using standardized criteria for RA, 22 OA, 23 back pain, 24 and gout arthritis (GA). 25

Data quality assurance

Data collectors were given 3 days of training in data collection procedures and research ethics. The data collection process was supervised by the investigator. The collected data were checked for completeness, accuracy, and consistency by the investigator. The coded data were checked for accuracy and completeness before being analyzed. Trained persons conducted interviews and anthropometric measurements in at least two visits to participants’ homes.

Statistical Analysis

The data were checked, cleaned, entered into EpiData version 3.1, and exported for analysis to STATA version 14. To summarize the data and identify the association of independent variables with outcome variables, descriptive statistics were used.

Ethical consideration

The actual gathering of data started after the study was approved by Debre Markos University Ethical Review Board. Local administrative bodies were also communicated about the study, and permission was obtained before the study. Finally, informed written consent was obtained from the participants.

Operational definition

MSDs are defined in this study as pain and/or discomfort in at least one of the following body parts at least once in the past 6 months: neck, shoulder, upper back, elbow, lower back, wrist/hand, hips/thighs, knee, or ankle/feet.

Result

Population characteristics

A total of 836 participants aged 18–82 years were interviewed in this study, with 244 (29.2%) aged 36–45 years. With regard to educational level, 271 (32.4%) can read and write and 223 (26.7%) completed primary school (Table 1).

Table 1.

Sociodemographic characteristics of the respondents.

Variables Frequency (%)
Sex
 Male 334 (40.0)
 Female 502 (60.0)
Age (years)
 18–35 169 (20.2)
 36–45 244 (29.2)
 46–70 179 (21.4)
 70+ 244 (29.2)
Religion
 Orthodox 793 (94.9)
 Muslim 31 (3.7)
 Protestant 12 (1.4)
Educational status 82 (9.8)
 Unable to read and write 138 (16.5)
 Read and write only 271 (32.4)
 Primary 223 (26.7)
 Secondary 45 (5.4)
 Preparatory 77 (9.2)
 College and above 82 (9.8)
Occupation
 House wife 561 (67.1)
 Farmer 67 (8.0)
 Student 78 (9.3)
 Government employee 76 (9.1)
 Private employee 54 (6.5)
Marital status
 Single 35 (4.2)
 Married 700 (83.7)
 Widowed 28 (3.3)
 Divorced 69 (8.3)
 Separated 4 (.5)
Ethnicity
 Amhara 785 (93.9)
 Oromo 16 (1.9)
 Tigray 12 (1.4)
 Other 23 (2.8)

Magnitude and pattern of comorbidities of chronic MSDs

Almost one (40%) in four participants have at least one MSD. RA, OA, low back pain (LBP), and GA are the most common MSDs. Of these, chronic LBP was the most prevalent chronic MSD in both men and women. Back pain was the most prevalent MSD, affecting 134 (16%) of the population, followed by OA (84%) and other types of arthritis (RA 67 (8%), GA 50 (6%)). A total of 180 (21.5%) of those with a MSD also had at least one other chronic disease. The most common comorbidity (multimorbidity) patterns were hypertension (9.8%), diabetes (5.6%), obesity (3.9%), and others (2.2%). Females were more common than males to have chronic back pain (10.8% vs 5.3%) and OA (6.3% vs 3.7%), whereas all other conditions were equally prevalent in both genders (Table 2).

Table 2.

Disease characteristics of the study participants (n = 836).

Variable Categories Any MSDs
Yes, n (%) No, n (%)
335 (40.1) 501 (59.9)
MSD characteristics Pattern of MSDs
CBP OA RA GA
n (%) n (%) n (%) n (%)
Sex Female 90 (10.8) 53 (6.3) 40 (4.8) 31 (3.7)
Male 44 (5.3) 31 (3.7) 27 (3.2) 19 (2.3)
Age group (years) 18–35 19 (2.3) 16 (1.9) 13 (1.6) 10 (1.2)
36–45 27 (3.2) 17 (2.0) 20 (2.4) 15 (1.8)
46–70 35 (4.2) 25 (3.0) 13 (1.6) 13 (1.6)
70+ 53 (6.3) 26 (3.1) 21 (2.5) 12 (1.4)
Physical exercises Yes 23 (2.8) 18 (2.2) 14 (1.7) 7 (0.8)
No 111 (13.3) 66 (7.9) 53 (6.3) 43 (5.1)
Working posture (condition) Bending 42 (5.0) 24 (2.9) 19 (2.3) 17 (2.0)
Standing 61 (7.3) 35 (4.2) 31 (3.7) 23 (2.8)
Static work 31 (3.7) 25 (3.0) 17 (2.0) 10 (1.2)
Working hours/day >8 92 (11.0) 62 (7.4) 45 (5.4) 38 (4.5)
⩽8 42 (5.0) 22 (2.6) 22 (2.6) 12 (1.4)
Chronic diseases No 62 (7.4) 39 (4.7) 31 (3.7) 23 (2.8)
Yes 72 (8.6) 45 (5.4) 36 (4.3) 27 (3.2)
Patterns of comorbidity Hypertension 40 (4.8) 34 (4.1) 5 (0.6) 3 (0.4)
Diabetes 12 (1.4) 4 (0.5) 25 (3.0) 6 (0.7)
Obesity (BMI >30 kg/m2) 7 (0.8) 5 (0.6) 8 (1.0) 13 (1.6)
Others a 3 (0.4) 4 (0.5) 6 (0.7) 5 (0.6)

RA: rheumatoid arthritis; CBP: chronic back pain; GA: gout arthritis; OA: osteoarthritis; BMI: body mass index; MSD: musculoskeletal disorder.

a

Heart disease, mental and behavioral problems.

Discussion

MSDs, which include more than 150 different conditions, have a major impact on quality of life and well-being due to acute and chronic pain, discomfort, physical restrictions, comorbidity, and mental health challenges. 1

MSDs caused approximately 1.3 billion prevalent cases, 121.3 thousand deaths, and 138.7 million disability-adjusted life years (DALYs) globally in 2017. 26 MSDs have historically received less attention in Africa, particularly in Sub-Saharan Africa, and many African nations’ scarce health resources are being prioritized to meet the issues of infectious and communicable diseases. 27 Although various studies have been conducted on the prevalence of MSDs worldwide, there has been no research done on the magnitude and patterns of MSD comorbidity in Ethiopia.

Thus, this study aimed to assess the magnitude and patterns of comorbidities of chronic MSDs among the population in Northwest Ethiopia.

The overall prevalence of MSDs among the population in Northwest Ethiopia was found to be 40.1%. This finding was comparable to that of a study done in Vietnam, 28 South Asia, eastern sub-Saharan Africa, and central Latin America. 26 However, the current study’s findings were lower in comparison with research conducted in the United Kingdom (52%), Norway (56%), Sweden (64%), and Taiwan (90%),2932 but higher than the research conducted in the United States (29.0%), 33 France (from 10% to 50%), 34 and Pakistan (31.6%). 35 This discrepancy could be attributed to changes in methodology, study setting, differences in geographical areas, sample size, individual pain perception, cultural differences, and study participants’ income which are related to differences in work conditions and the impact of occupational hazards. 36 Another reason for the disparity could be the age of the participants, as well as the different assessment tools used to evaluate MSDs. MSD prevalence has been observed to vary across geographical boundaries and occupational categories, 37 and the magnitude of MSDs varies due to a variety of data collection tools, the subjectivity of terminologies, cultural differences in MSD perception and reporting, and organizational differences in work environments.

The patterns of multimorbidity among MSDs are assessed in this study. Because MSK diseases are such a clinically diverse group, the prevalence of multimorbidity may vary by subtype. Hypertension, diabetes, and obesity were the highest prevalence of multimorbidity of MSDs in this study. This was supported by the studies done in the WHO and the Lebanese Ministry of Health (MOH).38,39

Among major MSDs, chronic LBP has the highest prevalence in this study. A study reported that the prevalence of chronic LBP and OA ranged from 0.9% to 24%.4042

According to this study, females were more common than males to have chronic back pain (10.8% vs 5.3%) and OA (6.3 vs 3.7%), but the prevalence of all other disorders was relatively similar between males and females, which is supported by a study done in Australia. 43 The mechanism underlying these sex differences is unclear, but they could be due to differences in sex-related biological factors (hormones or physiology), differences in pain severity, or women’s tendency to perceive and cope with pain differently, as well as differences in social or psychological factors.44,45

According to COPCORD studies, the prevalence of RA was 0.4% in India and from rural areas of other developing countries has ranged from 3.95% to 8.5%. 46 The reason for the higher prevalence of OA in the current study compared with other rural areas would need to be researched further. Because of the high prevalence of these diseases and the need for healthcare in rural areas, these ailments should be treated at a low cost through early diagnosis and screening, linking to health institutions, and direct treatments at the village level through the public healthcare system. It was found in our study that 21.5% of participants had one or more MSDs. Comorbidity among persons with chronic MSDs differed by age, with older people having more comorbidities than younger ones. This is in line with a study conducted in Australia and Brazil, which indicated that as people got older, the number of chronic diseases increased. 47 This could be because as people get older, they are more likely to have physical and functional incapacities, which can reduce their quality of life. 48

Because of their extended duration, incapacitating effects, and continual use of healthcare services and resources, MSDs cannot be disregarded as minor problems. 49 MSDs can have considerable medical, economic, and societal impacts, as well as play a significant role in the population’s health profile. 50 Hence, while planning healthcare services and determining research priorities and implementation across the health system, specific concerns tailored to MSD screening and management must be taken into account. Despite significant investment in reducing the prevalence of MSDs in LMICs, little research is available to inform policy and decision-making. As a result, more research is needed to establish consolidated evidence on a global level, as well as in developing countries in particular.

Limitation of the study

The data limitations and gaps associated with these analyses should be kept in mind for future research and interpretation of the primary findings provided here. The results of this study should be interpreted with some limitations. Because the sample was obtained from community-dwelling groups and did not include those living in care facilities or hospitalized patients, a selection bias toward sampling healthier respondents is anticipated. Furthermore, because some of the data collected are based on self-reported symptoms, recall bias may exist. Despite these limitations, this is the first study in the region to use a COPCORD questionnaire to assess the magnitude and patterns of comorbidities of MSDs in Northwest Ethiopia.

Conclusion

Almost one in four participants have at least one MSD in Northwest Ethiopia. RA, OA, LBP, and GA were the most common MSDs. The most common comorbidity patterns were hypertension, diabetes, obesity, and others. MSDs have a high prevalence of comorbidities, which should be incorporated in the patient’s routine workup and integrated with a holistic approach to the patient for screening and future standardized comorbidity management programs.

An in-depth investigation of the MSK burden at the national level will be critical for implementing evidence-based strategies, as well as early detection and screening, linking to health institutions, and direct interventions.

Supplemental Material

sj-docx-1-smo-10.1177_20503121221085109 – Supplemental material for Musculoskeletal disorders among the population in Northwest Ethiopia

Supplemental material, sj-docx-1-smo-10.1177_20503121221085109 for Musculoskeletal disorders among the population in Northwest Ethiopia by Yoseph Merkeb Alamneh, Bickes Wube Sume and Abtie Abebaw Shiferaw in SAGE Open Medicine

Acknowledgments

We would like to express our gratitude to the study participants, data collectors, and supervisors, including Getachew Chane, Mengistu Ayele, and Asfaw Gerbi.

Footnotes

Authors’ contributions: YMA and AAS wrote the proposal and participated in data collection; approved the proposal with some revisions; developed the design and methodology of the study, literature review, and quality evaluation. YMA and BWS performed statistical analysis, data interpretation, and drafting of the article; developed the study design and protocol, literature review, statistical analysis, interpretation of the data, and developing drafts of the article. All authors read and approved the final article.

Availability of data and material: The datasets analyzed during the current study are available from the corresponding author upon reasonable request.

Declaration of conflicting interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Funding: The author(s) received no financial support for the research, authorship, and/or publication of this article.

Ethical approval: The ethical clearance letter has been received from the research and review committee at Debre Markos University (SOM 0013/14). In addition, before beginning, data collection permission was obtained from the hospital authority.

Informed consent: Informed written consent was received from each participant after explaining to them the research objectives. The participants were briefed on the study’s purpose, procedures, potential risks, and benefits. In addition, the participants were told that failure to agree to or withdraw from the study would not change or endanger their access to treatment.

ORCID iDs: Yoseph Merkeb Alamneh Inline graphic https://orcid.org/0000-0001-7612-4809

Bickes Wube Sume Inline graphic https://orcid.org/0000-0001-9707-6439

Abtie Abebaw Shiferaw Inline graphic https://orcid.org/0000-0002-8132-4001

Supplemental material: Supplemental material for this article is available online.

References

  • 1. Cieza A, Causey K, Kamenov K, et al. Global estimates of the need for rehabilitation based on the Global Burden of Disease Study 2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet 2020; 396(10267): 2006–2017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. da Costa BR, Vieira ER. Risk factors for work-related musculoskeletal disorders: a systematic review of recent longitudinal studies. Am J Ind Med 2010; 53(3): 285–323. [DOI] [PubMed] [Google Scholar]
  • 3. Rabiei M, Shakiba M, Dehgan-Shahreza H, et al. Musculoskeletal disorders in dentists. Int J Occup Hyg 2012; 4(1): 36–40. [Google Scholar]
  • 4. Hay SI, Abajobir AA, Abate KH, et al. Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 2017; 390(10100): 1260–1344. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Lin X, Xu Y, Xu J, et al. Global burden of noncommunicable disease attributable to high body mass index in 195 countries and territories, 1990–2017. Endocrine 2020. [DOI] [PubMed] [Google Scholar]
  • 6. Hoy D, Geere J-A, Davatchi F, et al. A time for action: opportunities for preventing the growing burden and disability from musculoskeletal conditions in low-and middle-income countries. Best Pract Res Clin Rheumatol 2014; 28(3): 377–393. [DOI] [PubMed] [Google Scholar]
  • 7. Adebajo A, Gabriel SE. Addressing musculoskeletal health inequity in Africa. Arthritis Care Res 2010; 62(4): 439–441. [DOI] [PubMed] [Google Scholar]
  • 8. Murray CJ, Lopez AD. The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020: summary. World Health Organization, 1996, https://apps.who.int/iris/handle/10665/41864 [Google Scholar]
  • 9. Vos T, Allen C, Arora M, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 2016; 388(10053): 1545–1602. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Wanyonyi N, Frantz J. Prevalence of work-related musculoskeletal disorders in Africa: a systematic review. Physiotherapy 2015; 101: e1604–e1605. [Google Scholar]
  • 11. Al-Hourani Z, Nazzal M, Khader Y, et al. Work-related musculoskeletal disorders among Jordanian dental technicians: prevalence and associated factors. Work 2017; 56(4): 617–623. [DOI] [PubMed] [Google Scholar]
  • 12. Roquelaure Y, Bodin J, Descatha A, et al. Musculoskeletal disorders: how to recognize them as occupational disease. Rev Prat 2018; 68(10): 1132–1134. [PubMed] [Google Scholar]
  • 13. Gebreyesus T, Nigussie K, Gashaw M, et al. The prevalence and risk factors of work-related musculoskeletal disorders among adults in Ethiopia: a study protocol for extending a systematic review with meta-analysis of observational studies. Syst Rev 2020; 9(1): 1–6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Barbe MF, Barr AE. Inflammation and the pathophysiology of work-related musculoskeletal disorders. Brain Behav Immun 2006; 20(5): 423–429. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. Brooks PM. The burden of musculoskeletal disease—a global perspective. Clin Rheumatol 2006; 25(6): 778–781. [DOI] [PubMed] [Google Scholar]
  • 16. Tamene A, Mulugeta H, Ashenafi T, et al. Musculoskeletal disorders and associated factors among vehicle repair workers in Hawassa City, Southern Ethiopia. J Environ Public Health 2020; 2020: 9472357. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. Kasaw Kibret A, Fisseha Gebremeskel B, Embaye Gezae K, et al. Work-related musculoskeletal disorders and associated factors among bankers in Ethiopia, 2018. Pain Res Manag 2020; 2020: 8735169. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18. Dagne D, Abebe SM, Getachew A. Work-related musculoskeletal disorders and associated factors among bank workers in Addis Ababa, Ethiopia: a cross-sectional study. Environmental Health and Preventive Medicine 2020; 25(1): 33. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. Mekonnen TH. The magnitude and factors associated with work-related back and lower extremity musculoskeletal disorders among barbers in Gondar Town, Northwest Ethiopia, 2017: a cross-sectional study. PLoS ONE 2019; 14(7): e0220035. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. Office of the Population and Housing Census Commission. Summary and statistical report of the 2007 population and housing census: population size by age and sex. Addis Ababa, Ethiopia: Population Census Commission, 2008. [Google Scholar]
  • 21. Bennett K, Cardiel M, Ferraz M, et al. Community screening for rheumatic disorder: cross cultural adaptation and screening characteristics of the COPCORD Core Questionnaire in Brazil, Chile, and Mexico. The PANLAR-COPCORD Working Group—Pan American League of Associations for Rheumatology. Community oriented programme for the control of rheumatic disease. J Rheumatol 1997; 24(1): 160–168. [PubMed] [Google Scholar]
  • 22. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31(3): 315–324. [DOI] [PubMed] [Google Scholar]
  • 23. Altman R, Alarcon G, Appelrouth D, et al. The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hand. Arthritis Rheum 1990; 33(11): 1601–1610. [DOI] [PubMed] [Google Scholar]
  • 24. Dougados M, Linden SVD, Juhlin R, et al. The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum 1991; 34(10): 1218–1227. [DOI] [PubMed] [Google Scholar]
  • 25. Alvarez-Nemegyei J, Pelaez-Ballestas I, Rodriguez-Amado J, et al. Prevalence of rheumatic regional pain syndromes in adults from Mexico: a community survey using COPCORD for screening and syndrome-specific diagnostic criteria. J Rheumatol Suppl 2011; 86: 15–20. [DOI] [PubMed] [Google Scholar]
  • 26. Safiri S, Kolahi AA, Cross M, et al. Prevalence, deaths, and disability-adjusted life years due to musculoskeletal disorders for 195 countries and territories 1990–2017. Arthritis Rheumatol 2021; 73(4): 702–714. [DOI] [PubMed] [Google Scholar]
  • 27. Mody GM. Rheumatology in Africa—challenges and opportunities. Arthritis Res Ther 2017; 19(1): 1–3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28. Luan HD, Hai NT, Xanh PT, et al. Musculoskeletal disorders: prevalence and associated factors among district hospital nurses in Haiphong, Vietnam. Biomed Res Int 2018; 2018: 3162564. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29. Woods V, Buckle P. An investigation into the design and use of workplace cleaning equipment. Int J Ind Ergonom 2005; 35(3): 247–266. [Google Scholar]
  • 30. Lasrado OE, Møllerløkken OJ, Moen BE, et al. Musculoskeletal symptoms among hospital cleaners. Arch Environ Occup Health 2017; 72(2): 87–92. [DOI] [PubMed] [Google Scholar]
  • 31. Unge J, Ohlsson K, Nordander C, et al. Differences in physical workload, psychosocial factors and musculoskeletal disorders between two groups of female hospital cleaners with two diverse organizational models. Int Arch Occup Environ Health 2007; 81(2): 209–220. [DOI] [PubMed] [Google Scholar]
  • 32. Woods V, Buckle P. Musculoskeletal ill health amongst cleaners and recommendations for work organisational change. Int J Ind Ergonom 2006; 36(1): 61–72. [Google Scholar]
  • 33. Lipscomb J, Trinkoff A, Brady B, et al. Health care system changes and reported musculoskeletal disorders among registered nurses. Am J Public Health 2004; 94(8): 1431–1435. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34. Pelissier C, Fontana L, Fort E, et al. Occupational risk factors for upper-limb and neck musculoskeletal disorder among health-care staff in nursing homes for the elderly in France. Ind Health 2014; 52(4): 334–346. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35. Rathore FA, Attique R, Asmaa Y. Prevalence and perceptions of musculoskeletal disorders among hospital nurses in Pakistan: a cross-sectional survey. Cureus 2017; 9(1): e1001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36. Zock J-P. World at work: cleaners. Occup Environ Med 2005; 62(8): 581–584. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37. Smith DR, Kondo N, Tanaka E, et al. Musculoskeletal disorders among hospital nurses in rural Japan. Rural Remote Health 2003; 3(3): 241. [PubMed] [Google Scholar]
  • 38. World Health Organization. The burden of musculoskeletal conditions at the start of the new millennium: report of a WHO scientific group, 2003, https://apps.who.int/iris/handle/10665/42721 [PubMed]
  • 39. Zeidan RK, Farah R, Chahine MN, et al. Prevalence and correlates of coronary heart disease: first population-based study in Lebanon. Vasc Health Risk Manag 2016; 12: 75–84. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40. Garcia JB, Hernandez-Castro JJ, Nunez RG, et al. Prevalence of low back pain in Latin America: a systematic literature review. Pain Physician 2014; 17(5): 379–391. [PubMed] [Google Scholar]
  • 41. Pereira D, Peleteiro B, Araujo J, et al. The effect of osteoarthritis definition on prevalence and incidence estimates: a systematic review. Osteoarthritis Cartilage 2011; 19(11): 1270–1285. [DOI] [PubMed] [Google Scholar]
  • 42. Cross M, Smith E, Hoy D, et al. The global burden of hip and knee osteoarthritis: estimates from the global burden of disease 2010 study. Ann Rheum Dis 2014; 73(7): 1323–1330. [DOI] [PubMed] [Google Scholar]
  • 43. Withers HG, Glinsky JV, Chu J, et al. Face-to-face physiotherapy compared with a supported home exercise programme for the management of musculoskeletal conditions: protocol of a multicentre, randomised controlled trial-the REFORM trial. BMJ Open 2021; 11(5): e041242. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44. Strazdins L, Bammer G. Women, work and musculoskeletal health. Soc Sci Med 2004; 58(6): 997–1005. [DOI] [PubMed] [Google Scholar]
  • 45. Keefe FJ, Lefebvre JC, Egert JR, et al. The relationship of gender to pain, pain behavior, and disability in osteoarthritis patients: the role of catastrophizing. Pain 2000; 87(3): 325–334. [DOI] [PubMed] [Google Scholar]
  • 46. Joshi VR, Bang AA, Bhojraj SY, et al. Clinical pattern and prevalence of rheumatic diseases among adults: a community-based cross-sectional study in rural Gadchiroli, India. Journal of Global Health Reports 2021; 5: e2021040. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47. Fejer R, Ruhe A. What is the prevalence of musculoskeletal problems in the elderly population in developed countries? A systematic critical literature review. Chiropr Man Therap 2012; 20(1): 1–52. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48. Carvalho Bittar ST, Pinto FR, Ferreira M, et al. Manual for guided home exercises for osteoarthritis of the knee. Clinics 2010; 65(8): 775–780. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49. Duffield SJ, Ellis BM, Goodson N, et al. The contribution of musculoskeletal disorders in multimorbidity: implications for practice and policy. Best Pract Res Clin Rheumatol 2017; 31(2): 129–144. [DOI] [PubMed] [Google Scholar]
  • 50. Badley E, Webster G, Rasooly I. The impact of musculoskeletal disorders in the population: are they just aches and pains? Findings from the 1990 Ontario Health Survey. J Rheumatol 1995; 22(4): 733–739. [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

sj-docx-1-smo-10.1177_20503121221085109 – Supplemental material for Musculoskeletal disorders among the population in Northwest Ethiopia

Supplemental material, sj-docx-1-smo-10.1177_20503121221085109 for Musculoskeletal disorders among the population in Northwest Ethiopia by Yoseph Merkeb Alamneh, Bickes Wube Sume and Abtie Abebaw Shiferaw in SAGE Open Medicine


Articles from SAGE Open Medicine are provided here courtesy of SAGE Publications

RESOURCES